A Comprehensive Overview of Individual Participant Data (IPD) Meta-Analysis

High-Impact Journals

Interesting topics

A Comprehensive Overview of Individual Participant Data (IPD) Meta-Analysis

Meta-analysis is commonly considered one of the best tools available for the synthesis of evidence. Conventional meta-analysis is commonly performed with the help of aggregate data obtained from published works. Nevertheless, many scientists prefer to apply Individual Participant Data Meta-analysis (IPD-MA), which offers a more sophisticated and accurate evidence synthesis tool. The difference between these approaches lies in the use of original data from participants rather than the summary statistics from publications by the researchers.
The individual participant data meta-analysis can be called the gold standard of evidence synthesis due to the higher level of analysis accuracy, uniformity of data processing, and possibility of analysing various features of participants affecting the results. The following paper will introduce the basics of IPD Meta-Analysis, its methods, advantages, disadvantages, and applications. [1]

1. What Is Individual Participant Data Meta-Analysis?

Definition of what is IPD Meta-Analysis (Individual Participant Data Meta-Analysis (IPD-MA)) IPD-MA refers to the process whereby raw data from each participant in different eligible studies is obtained and put together in one dataset. As compared to traditional meta-analysis, where the odds ratio or mean difference is calculated, IPD makes it possible for researchers to conduct standardised analysis of all studies. [2]

2. Why Is IPD Meta-Analysis Important?

Clinical Research Meta-Analysis using IPD is associated with numerous benefits compared to conventional evidence synthesis techniques.

Primary Advantages

  • Equipped with high statistical power due to a larger sample size.
  • Provides the opportunity for conducting sub-group and interaction analysis.
  • Lessens reporting bias.
  • Permits standardisation of outcome definitions.
  • Facilitates patient-level characteristic study.
  • Provides better accuracy of treatment effect estimates.

This approach is especially beneficial in the context of healthcare research and clinical trials.

3. Steps Involved in Conducting an IPD Meta-Analysis

Carrying out an IPD meta-analysis entails thorough preparation and teamwork by researchers.

  • Research question and protocol formulation – Specify the goals, procedures and inclusion/exclusion criteria beforehand.
  • Systematic literature search – Look for all the pertinent publications from databases.
  • Selection of eligible studies – Pick out the studies that comply with inclusion/exclusion criteria.
  • Collection of individual participant data – Contact study authors for individual patient datasets.
  • Data validation and cleaning – Data checking for accuracy, validity and consistency.
  • Variable harmonisation – Making sure that variables are standardised between studies.
  • IPD Data Synthesis Techniques – Performing necessary statistical tests on collected datasets.

4. Statistical Approaches in IPD Meta-Analysis

Two major analytical strategies are widely employed: [3]

Single-Stage StrategyTwo-Stage Strategy

Analysis of all data collected from all studies is done in one statistical model.

Pros:

  • More flexibility
  • More capable in dealing with interactions
  • Improved subgroup analysis

Each study is analysed first and then combined.

Pros:

  • Easier implementation
  • Easier to understand
  • Well-known by traditional meta-analysis practitioners

Which strategy should be chosen is determined by the goal of the research.

5. Applications and Issues Related to IPD Meta-Analysis

IPD meta-analysis is extensively applied in different fields for the analysis of clinical trials, effectiveness of medications, prognostic factors, diagnostic tests, public health measures, and personalised medicine. For instance, in cancer research, it can be used to identify factors that make patients more responsive to treatments.

Some of the difficulties associated with the application of IPD meta-analysis include the lack of availability of original databases, data privacy concerns, inconsistency in the definition of variables, the expense of the process, and the need for efficient data management techniques. [4]

6. Best Practices for Successful IPD Meta-Analysis

To achieve a high level of quality and validity of studies, certain guidelines should be followed.

Guidelines

  • Create an elaborate protocol before the collection of data.
  • Observe PRISMA-IPD guidelines for reporting.
  • Employ standard procedures for data management.
  • Perform thorough quality assessment.
  • Maintain transparency throughout the procedure.
  • Handle participant data in an ethically sound manner.

Connect with us to explore how we can support you in maintaining academic integrity and enhancing the visibility of your research across the world!

Contact Us

Conclusion

IPD Meta-Analysis is among the most advanced methods of evidence synthesis that are known today. The combination of data on the individual participant level, it allows for conducting more precise analysis, studying effects in subgroups and producing evidence of higher quality for making decisions. Even though there might be certain difficulties related to IPD data collection and management, its advantages usually compensate for such drawbacks. With the growth of various data-sharing projects, IPD meta-analysis will become even more widespread in medicine.

A Comprehensive Overview of Individual Participant Data (IPD) Meta-Analysis. Our Pubrica consultants are here to guide you. [Get Expert Publishing Support] or [Schedule a Free Consultation]

Frequently Asked Questions (FAQs)

IPD meta-analysis is a method where raw data from each participant across multiple studies is collected and analysed together in a single, standardised dataset.

Traditional meta-analysis uses summary results (like odds ratios), while IPD meta-analysis uses raw participant-level data, allowing more detailed and accurate analysis.

It provides higher statistical accuracy, enables subgroup analysis, reduces bias, and allows consistent data handling across studies.

Challenges include difficulty in obtaining raw data, privacy concerns, high cost, and complex data harmonisation.

It is widely used in clinical trials, oncology, epidemiology, public health research, and personalised medicine.

References

  1. Rai, E., Naik, V., Williams, A., & Kamath, M. S. (2025). Individual participant data (IPD) meta-analysis: An introduction – Narrative review. Indian journal of anaesthesia, 69(1), 153–160. https://doi.org/10.4103/ija.ija_1187_24
  2. Veroniki, A. A., Seitidis, G., Tsivgoulis, G., Katsanos, A. H., & Mavridis, D. (2023). An Introduction to Individual Participant Data Meta-analysis. Neurology, 100(23), 1102–1110. https://doi.org/10.1212/WNL.0000000000207078
  3. Thomas, D., Radji, S., & Benedetti, A. (2014). Systematic review of methods for individual patient data meta- analysis with binary outcomes. BMC medical research methodology, 14, 79. https://doi.org/10.1186/1471-2288-14-79
  4. Tierney, J. F., Vale, C., Riley, R., Smith, C. T., Stewart, L., Clarke, M., & Rovers, M. (2015). Individual Participant Data (IPD) Meta-analyses of Randomised Controlled Trials: Guidance on Their Use. PLoS medicine, 12(7), e1001855. https://doi.org/10.1371/journal.pmed.1001855